Iris Parent Holding CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Liminatus Pharma, Inc. is holding its 2026 Annual Meeting of Stockholders on August 3, 2026, to elect directors, ratify auditors, and approve a reverse stock split.